Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | PLPPR3 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Plppr3 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | PLPPR3 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Plppr3 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | PLPPR3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PLPPR3 mRNA | CTD | PMID:32109520 | PLPPR3 | Human | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Plppr3 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of PLPPR3 exon | CTD | PMID:33297965 | PLPPR3 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Plppr3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PLPPR3 mRNA | CTD | PMID:36041667 | PLPPR3 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of PLPPR3 mRNA | CTD | PMID:24780913 | PLPPR3 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of PLPPR3 5' UTR and Benzo(a)pyrene results in increased methylation of PLPPR3 promoter | CTD | PMID:27901495 | PLPPR3 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PLPPR3 intron | CTD | PMID:30157460 | PLPPR3 | Human | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Plppr3 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLPPR3 mRNA | CTD | PMID:31199487 | PLPPR3 | Human | bisphenol A | decreases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of PLPPR3 mRNA | CTD | PMID:25181051 | PLPPR3 | Human | bisphenol A | decreases expression | ISO | Plppr3 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of PLPPR3 mRNA | CTD | PMID:32156529 | PLPPR3 | Human | bisphenol A | multiple interactions | ISO | Plppr3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PLPPR3 mRNA | CTD | PMID:36041667 | PLPPR3 | Human | bisphenol F | multiple interactions | ISO | Plppr3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PLPPR3 mRNA | CTD | PMID:36041667 | PLPPR3 | Human | bromobenzene | decreases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | bromobenzene results in decreased expression of PLPPR3 mRNA | CTD | PMID:32479839 | PLPPR3 | Human | Butylbenzyl phthalate | multiple interactions | ISO | Plppr3 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLPPR3 mRNA | CTD | PMID:31199487 | PLPPR3 | Human | carbon nanotube | increases expression | ISO | Plppr3 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of PLPPR3 mRNA | CTD | PMID:25554681 | PLPPR3 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of PLPPR3 mRNA | CTD | PMID:27594783 | PLPPR3 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of PLPPR3 mRNA | CTD | PMID:27392435 | PLPPR3 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of PLPPR3 mRNA | CTD | PMID:27392435 | PLPPR3 | Human | Cuprizon | increases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of PLPPR3 mRNA | CTD | PMID:26577399 | PLPPR3 | Human | dibutyl phthalate | multiple interactions | ISO | Plppr3 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLPPR3 mRNA | CTD | PMID:31199487 | PLPPR3 | Human | diethyl phthalate | multiple interactions | ISO | Plppr3 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLPPR3 mRNA | CTD | PMID:31199487 | PLPPR3 | Human | diisobutyl phthalate | multiple interactions | ISO | Plppr3 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLPPR3 mRNA | CTD | PMID:31199487 | PLPPR3 | Human | diisononyl phthalate | multiple interactions | ISO | Plppr3 (Rattus norvegicus) | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLPPR3 mRNA | CTD | PMID:31199487 | PLPPR3 | Human | furan | decreases methylation | ISO | Plppr3 (Rattus norvegicus) | 6480464 | furan results in decreased methylation of PLPPR3 gene | CTD | PMID:27387713 | PLPPR3 | Human | furan | increases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | furan results in increased expression of PLPPR3 mRNA | CTD | PMID:27387713 | PLPPR3 | Human | gentamycin | decreases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of PLPPR3 mRNA | CTD | PMID:33387578 | PLPPR3 | Human | glycidol | decreases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | glycidol results in decreased expression of PLPPR3 mRNA | CTD | PMID:24915197 | PLPPR3 | Human | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of PLPPR3 mRNA | CTD | PMID:33647349 | PLPPR3 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PLPPR3 mRNA | CTD | PMID:35811015 | PLPPR3 | Human | N-methyl-4-phenylpyridinium | decreases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of PLPPR3 mRNA | CTD | PMID:28801915 | PLPPR3 | Human | paracetamol | decreases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of PLPPR3 mRNA | CTD | PMID:33387578 | PLPPR3 | Human | PCB138 | multiple interactions | ISO | Plppr3 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | PLPPR3 | Human | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of PLPPR3 mRNA | CTD | PMID:26079696 | PLPPR3 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PLPPR3 mRNA | CTD | PMID:35811015 | PLPPR3 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of PLPPR3 mRNA | CTD | PMID:25895662 | PLPPR3 | Human | sodium arsenite | increases expression | ISO | Plppr3 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of PLPPR3 mRNA | CTD | PMID:37682722 | PLPPR3 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of PLPPR3 mRNA | CTD | PMID:31533062 | PLPPR3 | Human | thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of PLPPR3 mRNA | CTD | PMID:27188386 | PLPPR3 | Human | thioacetamide | increases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of PLPPR3 mRNA | CTD | PMID:34492290 | PLPPR3 | Human | trichloroethene | increases expression | ISO | Plppr3 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of PLPPR3 mRNA | CTD | PMID:33387578 | PLPPR3 | Human | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of PLPPR3 mRNA | CTD | PMID:30510588 | PLPPR3 | Human | trovafloxacin | increases expression | ISO | Plppr3 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of PLPPR3 mRNA | CTD | PMID:35537566 | PLPPR3 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of PLPPR3 gene | CTD | PMID:29154799 | PLPPR3 | Human | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of PLPPR3 mRNA | CTD | PMID:27188386 | |